Abstract:The pathogenesis of Alzheimer's disease (AD) remains elusive. Brain glucose hypometabolism, an invariant feature, precedes and closely correlates with clinical symptoms and signs in AD. To clarify the mechanism of cerebral glucose metabolism will help to understand AD pathogenesis. Cerebral glucose metabolism was evaluated by FDG-PET in AD patients and the mice with thiamine deficiency (TD) by diet deprivation. Brain amyloid deposit was measured by PiB-PET. Thiamine diphosphate (TDP), thiamine monophosphate, and thiamine levels were detected by high performance liquid chromatography. The diagnostic value of blood TDP level for AD was analyzed. The effects of thiamine metabolism on dendrtic branching, spine, and soma size of enurons were investigated by inhibiting thiamine pyrophosphokinase (TPK), the key enzyme of thiamine metabolism, and transporters (SLC19A2, SLC19A3, SLC25A19) via TPK antagonist (pyrithiamine) and/or RNA interference. Blood TDP level in AD patients and blood and brain TDP levels in TD mice were significantly reduced as compared with that in control groups (n=1199 for human subjects and n=6 for mice), patients with vascular dementia (n=67) and frontotemporal dementia (n=13, all P<0.001). Blood TDP level in AD patients (n=14) and blood/brain TDP levels in TD mice (n=6) was closely correlated with glucose metabolism of cotices examined. Blood TDP level exhibited a promising value for AD diagnosis (0.830 of AUC, 76.5% of sensititvity, and 77.5% of specificity) and differential diagnosis from vascular dementia and frontotemporal dementia. Brain amyloid deposit in AD patients was not significantly correlated with blood TDP level (n=32). Pyrithiamine and RNA interference against TPK and transporters (SLC19A2, SLC19A3, SLC25A19) significantly reduced dendritic brainching, spine density, and soma size of neurons (n=9-64 in 3 batches of cultured hippocampal neurons). The disruption of thiamie metabolism in AD contributes to brain glucose hypometabolism and neurodegeneration. Combinging with the previous studies, we propose that AD is a metabolic disorder and hypothesize that disrutped thiamiine metabolism directly contributes to AD pathogenesis by perturbing glucose utilization and inducing multiple pathogenic factors in the brain. Altered thiamine metabolism is a useful diagnostic biomarker for AD and a potential target for the disease-modifying study.

Thiamine Deficiency Induced β-amyloid Deposition and Tau Hyperphosphorylation

Exposure to Pyrithiamine Increases β-Amyloid Accumulation, Tau Hyperphosphorylation, and Glycogen Synthase Kinase-3 Activity in the Brain

The mechanism and consequences of amyloid-β modulating thiamine pyrophosphokinase-1 expression in microglia

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Thiamine Deficiency Modulates p38MAPK and Heme Oxygenase-1 in Mouse Brain: Association with Early Tissue and Behavioral Changes

Thiamine pyrophosphokinase-1 deficiency in neurons drives Alzheimer's multiple pathophysiological alterations

P1‐078: Reduced Thiamine Diphosphate Level Contributes to Brain Glucose Hypometabolism and Neurodegeneration in Alzheimer's Disease

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Powerful Beneficial Effects of Benfotiamine on Cognitive Impairment and Beta-Amyloid Deposition in Amyloid Precursor Protein/Presenilin-1 Transgenic Mice

Thiamine Diphosphate Reduction Strongly Correlates with Brain Glucose Hypometabolism in Alzheimer’s Disease, Whereas Amyloid Deposition Does Not

Thiamine Deficiency Causes Long-Lasting Neurobehavioral Deficits in Mice

Thiamine Deficiency Contributes to Synapse and Neural Circuit Defects

Changes of Cognitive Function and Hippocampal Long-Term Potentiation in Adult Mice in Early Stage of Thiamine Deficiency

Impaired Hippocampal Neurogenesis is Involved in Cognitive Dysfunction Induced by Thiamine Deficiency at Early Pre-Pathological Lesion Stage

Decreased Activity of Transketolase is Related With Regionally Selective Damage of Brain Midline in Wernicke Encephalopathy

Metformin Treatment Attenuates Tau Seeding in Neuritic Plaques

Metformin Attenuates Plaque-Associated Tau Pathology and Reduces Amyloid-Β Burden in APP/PS1 Mice

Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy

Decreased Transketolase Activity Contributes to Impaired Hippocampal Neurogenesis Induced by Thiamine Deficiency.

Thiamine pyrophosphokinase deficiency induces Alzheimer’s pathology

Tβ4 and PDTC displayed recovery on the glial and neuronal alterations in an early Alzheimer’s disease model